Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
53
CME Quote, Financials, Valuation and Earnings
Last price:
$276.73
Seasonality move
:
4.85%
Day range:
$274.99 - $277.00
52-week range:
$224.62 - $290.79
Dividend yield:
1.81%
P/E ratio:
26.79x
P/S ratio:
15.56x
P/B ratio:
3.54x
Volume:
580K
Avg. volume:
2M
1-year change:
15.41%
Market cap:
$99.7B
Revenue:
$6.1B
EPS (TTM):
$10.32
Analysts' Opinion
-
Consensus RatingCME Group, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 6 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $287.07, CME Group, Inc. has an estimated upside of 3.87% from its current price of $276.38.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $209.00 representing 100% downside risk from its current price of $276.38.
Fair Value
-
According to the consensus of 10 analysts, CME Group, Inc. has 3.87% upside to fair value with a price target of $287.07 per share.
CME vs. S&P 500
-
Over the past 5 trading days, CME Group, Inc. has underperformed the S&P 500 by -0.46% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
CME Group, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CME Group, Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter CME Group, Inc. reported revenues of $1.5B.
Earnings Growth
-
CME Group, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter CME Group, Inc. reported earnings per share of $2.49.
Enterprise value:
100.9B
EV / Invested capital:
3.16x
Price / LTM sales:
15.56x
EV / EBIT:
24.26x
EV / Revenue:
15.77x
PEG ratio (5yr expected):
3.16x
EV / Free cash flow:
24.70x
Price / Operating cash flow:
24.38x
Enterprise value / EBITDA:
22.47x
Gross Profit (TTM):
$5.3B
Return On Assets:
2.35%
Net Income Margin (TTM):
58.87%
Return On Equity:
13.68%
Return On Invested Capital:
12.02%
Operating Margin:
63.25%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $5.3B | $6B | $6.4B | $1.6B | $1.5B | |
| Gross Profit | $4.3B | $5B | $5.3B | $1.3B | $1.3B | |
| Operating Income | $3.2B | $3.8B | $4.2B | $1B | $972.6M | |
| EBITDA | $3.6B | $4.2B | $4.5B | $1.1B | $1.1B | |
| Diluted EPS | $8.38 | $9.51 | $10.32 | $2.50 | $2.49 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $151.6B | $143.3B | $90.8B | $103.1B | $152.8B | |
| Total Assets | $186.8B | $178.4B | $125.6B | $137.8B | $187.1B | |
| Current Liabilities | $150.4B | $140.6B | $87.9B | $100.8B | $149.6B | |
| Total Liabilities | $159.5B | $150.2B | $97.4B | $109.6B | $159B | |
| Total Equity | $27.3B | $28.3B | $28.2B | $28.2B | $28.2B | |
| Total Debt | $3.2B | $3.9B | $3.8B | $3B | $3.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $3.4B | $3.7B | $4.2B | $1B | $968.1M | |
| Cash From Investing | $15.6M | -$77.7M | -$78.4M | -$29.5M | -$19.1M | |
| Cash From Financing | -$56B | $8.6B | $45.6B | $13.3B | $6.4B | |
| Free Cash Flow | $3.3B | $3.6B | $4.1B | $973.2M | $949.7M | |
CME
Sector
Market Cap
$99.7B
$570M
Price % of 52-Week High
95.05%
92.18%
Dividend Yield
1.81%
1.57%
Shareholder Yield
3.99%
3.1%
1-Year Price Total Return
15.41%
7.3%
Beta (5-Year)
0.277
0.478
Dividend yield:
1.81%
Annualized payout:
$10.40
Payout ratio:
50.25%
Growth streak:
6 years
Technicals
8-day SMA
Buy
Level
$272.39
200-day SMA
Buy
Level
$271.19
Bollinger Bands (100)
Buy
Level
264.12 - 276.9
Chaikin Money Flow
Buy
Level
588.9M
20-day SMA
Buy
Level
$273.46
Relative Strength Index (RSI14)
Buy
Level
55.13
ADX Line
Buy
Level
10.76
Williams %R
Sell
Level
-5.2409
50-day SMA
Buy
Level
$272.43
MACD (12, 26)
Sell
Level
-0.10
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
674.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.6387)
Sell
CA Score
(Annual)
Level (-1.6972)
Buy
Beneish M-Score
(Annual)
Level (-3.1888)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (0.3932)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.
Stock Forecast FAQ
In the current month, CME has received 3 Buy ratings 6 Hold ratings, and 1 Sell ratings. The CME average analyst price target in the past 3 months is $287.07.
-
Where Will CME Group, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that CME Group, Inc. share price will rise to $287.07 per share over the next 12 months.
-
What Do Analysts Say About CME Group, Inc.?
Analysts are divided on their view about CME Group, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CME Group, Inc. is a Sell and believe this share price will drop from its current level to $209.00.
-
What Is CME Group, Inc.'s Price Target?
The price target for CME Group, Inc. over the next 1-year time period is forecast to be $287.07 according to 10 Wall Street analysts, 3 of them rate the stock a Buy, 1 rates the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is CME A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CME Group, Inc. is a Hold. 6 of 10 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CME?
You can purchase shares of CME Group, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CME Group, Inc. shares.
-
What Is The CME Group, Inc. Share Price Today?
CME Group, Inc. was last trading at $276.73 per share. This represents the most recent stock quote for CME Group, Inc.. Yesterday, CME Group, Inc. closed at $276.38 per share.
-
How To Buy CME Group, Inc. Stock Online?
In order to purchase CME Group, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CME Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CME
Sector
P/E ratio
26.79x
12.24x
PEG ratio
3.16x
0.31x
P/B ratio
3.54x
1.11x
Price / LTM sales
15.56x
1.85x
Growth Metrics
CME
Sector
Revenue growth
-2.95%
5.54%
Earnings growth
-0.64%
14.87%
Revenue (5-year growth)
4.67%
8.85%
Earnings forecast
$2.63
$0.62
Profitability
CME
Sector
Profitability FY 2024
$5B
--
Return on invested capital
12.02%
5.03%
Return on assets
2.35%
1.01%
Return on equity
13.68%
9.68%
Earnings Date
Last Earnings Date
Oct
22
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Jan
21
Balance Sheet
CME
Sector
Total cash
$2.6B
$431.4M
Short term investments
$113.2M
$211.3M
Total assets
$137.6B
$3.1B
Long term debt
$3.7B
$79.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 1.54% over the past day.
Buy
64
ZCSH alert for Dec 26
Grayscale Zcash Trust (ZEC) [ZCSH] is down 3.73% over the past day.
Buy
60
AAOI alert for Dec 26
Applied Optoelectronics, Inc. [AAOI] is down 9.39% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
